Skip to main content

Articles

Page 4 of 4

  1. The aim of our study was to prepare multifunctional, biocompatible nanoparticles for site-specific drug delivery. Hydrophilic nanoparticles with surface-adorned amine, carboxyl, or aldehyde groups, to be later...

    Authors: Sourav Chattopadhyay, Sandeep Kumar Dash, Totan Ghosh, Debasis Das, Panchanan Pramanik and Somenath Roy
    Citation: Cancer Nanotechnology 2013 4:42
  2. Limited efficacy of current first-line treatment for leukemia calls attention for further development of efficient strategies. Recently, much attention has been given to nanoparticle-based drug delivery system...

    Authors: Tanmoy Bhowmik, Partha Pratim Saha, Anjan Dasgupta and Antony Gomes
    Citation: Cancer Nanotechnology 2013 4:36
  3. Normal micelle microemulsion method was utilized for fabrication of organically modified silica (ORMOSIL) nanoparticles. The void and dye-doped nanoparticles were synthesized in nonpolar core of two different ...

    Authors: Vahid Shirshahi, Fereshteh Shamsipour, Amir Hassan Zarnani, Javad Verdi and Reza Saber
    Citation: Cancer Nanotechnology 2013 4:35
  4. Intratumoral and intralesional administration of anticancer drugs in gels and implantable formulations is gaining much importance on account of its advantage of site-specific delivery with highly dependable fr...

    Authors: Tanya Vohra, Inderpreet Kaur, Hemraj Heer and Rayasa Ramachandra Murthy
    Citation: Cancer Nanotechnology 2013 4:32
  5. Urinary tract infection (UTI) is a predominant condition in prostate cancer patients. Escherichia coli ORN178 (EC-178) is the uropathogen that causes recurrent infection by binding specifically to adhesins of pro...

    Authors: Pallavi Vedantam, George Huang and T. R. Jeremy Tzeng
    Citation: Cancer Nanotechnology 2013 4:33
  6. Broad spectrum therapeutic potential of curcumin is usually hampered by its photodegradation and low bioavailability. Present investigation was designed with an objective to develop transferrin-mediated solid ...

    Authors: Rohit S. Mulik, Jukka Mönkkönen, Risto O. Juvonen, Kakasaheb R. Mahadik and Anant R. Paradkar
    Citation: Cancer Nanotechnology 2012 3:31
  7. This article reports on the application of organically modified silica (ORMOSIL) nanoparticles as an efficient in vitro gene delivery system in the recent years. Based on that prime objective, the present stud...

    Authors: Chandrababu Rejeeth, Soundarapandian Kannan and Krishnasamy Muthuchelian
    Citation: Cancer Nanotechnology 2012 3:30
  8. As systemic cancer therapies improve and are able to control metastatic disease outside the central nervous system, the brain is increasingly the first site of relapse. The blood–brain barrier (BBB) represents...

    Authors: Mi-Ran Choi, Rizia Bardhan, Katie J. Stanton-Maxey, Sunil Badve, Harikrishna Nakshatri, Keith M. Stantz, Ning Cao, Naomi J. Halas and Susan E. Clare
    Citation: Cancer Nanotechnology 2012 3:29
  9. The development of smart nanoparticles that can exhibit the anti-cancer activity, introduces better efficacy and lower toxicity for treatment. The present study was aimed to evaluate the anti-cancer activity o...

    Authors: S. Chattopadhyay, S. P. Chakraborty, D. Laha, R. Baral, P. Pramanik and S. Roy
    Citation: Cancer Nanotechnology 2012 3:26
  10. PLGA nanoparticles, separately loaded with etoposide (ETN) and quercetin dihydrate (QDN), were prepared by adapting the solvent diffusion (nanoprecipitation) technique. The effect of formulation variables such...

    Authors: Smita Pimple, Arehalli S. Manjappa, Mukesh Ukawala and R. S. R. Murthy
    Citation: Cancer Nanotechnology 2012 3:27
  11. Cancer is one of the leading causes of death in most parts of the world and is a very serious cause of concern particularly in developing countries. In this work, we prepared and evaluated the aptamer-labeled ...

    Authors: Athulya Aravind, Saino Hanna Varghese, Srivani Veeranarayanan, Anila Mathew, Yutaka Nagaoka, Seiki Iwai, Takahiro Fukuda, Takashi Hasumura, Yasuhiko Yoshida, Toru Maekawa and D. Sakthi Kumar
    Citation: Cancer Nanotechnology 2012 3:24
  12. In the present study, poly(ethylene glycol)-b-poly(ε-caprolactone) micelles loaded with etoposide (ETO) were formulated and further conjugated with pentapeptide Glu-Ile-Leu-Asp-Val (EILDV) to target α4β1 integrin...

    Authors: Mukesh Ukawala, Tushar Rajyaguru, Kiran Chaudhari, A. S. Manjappa, R. S. R. Murthy and Rajiv Gude
    Citation: Cancer Nanotechnology 2011 2:23
  13. The remarkable health benefits of the chemical cocktails occluded within Vites vinefera (grapes) have been broadly used as dietary supplements and as natural pharmaceuticals in the treatment of various diseases i...

    Authors: Kanchana Amarnath, Nina Liza Mathew, Jayshree Nellore, Chagam Reddy Venkat Siddarth and Jayanthi Kumar
    Citation: Cancer Nanotechnology 2011 2:22
  14. In this paper, we have proposed a simple method to covalently conjugate biotin to magnetic nanoparticles, which can be targeted to the tumour sites by using pretargeting approach with avidin or streptavidin. M...

    Authors: Ram Prakash Chauhan, Gurjaspreet Singh, Sweta Singh, Narmada Bag, Manoj Patra, S. R. Vadera, Anil K. Mishra and Rashi Mathur
    Citation: Cancer Nanotechnology 2011 2:21
  15. Growth experiments of transplanted malignant tumors in the presence of water-soluble C60 fullerenes were performed on groups of mice. It was found that C60 fullerenes efficiently inhibit the growth of transplante...

    Authors: S. V. Prylutska, A. P. Burlaka, P. P. Klymenko, I. I. Grynyuk, Yu. I. Prylutskyy, Ch. Schütze and U. Ritter
    Citation: Cancer Nanotechnology 2011 2:20
  16. Photodynamic therapy (PDT) is a promising treatment methodology whereby diseased cells and tissues are destroyed by reactive oxygen species (ROS) by using a combination of light and photosensitizers (PS). The ...

    Authors: Krishnamoorthy Karthikeyan, Anish Babu, Sang-Jae Kim, Ramachandran Murugesan and Kadarkaraithangam Jeyasubramanian
    Citation: Cancer Nanotechnology 2011 2:19
  17. Celecoxib, a selective cyclooxygenase-2 inhibitor, has shown potential anticancerous activity against majority of solid tumors especially on patients with colon cancer. However, associations of serious side ef...

    Authors: Venkatesan Perumal, Shubhadeep Banerjee, Shubasis Das, R. K. Sen and Mahitosh Mandal
    Citation: Cancer Nanotechnology 2011 2:17
  18. Biofunctionalized gold and silver nanoparticles synthesized using different plant extracts of guava and clove in vitro anti-cancer efficacy against four different cancer cell lines human colorectal adenocarcin...

    Authors: Deshpande Raghunandan, Bhat Ravishankar, Ganachari Sharanbasava, D. Bedre Mahesh, Vasanth Harsoor, Manjunath S. Yalagatti, M. Bhagawanraju and A. Venkataraman
    Citation: Cancer Nanotechnology 2011 2:14
  19. The present study discusses evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in the Hep G2 cell line. Doxorubicin hydrochloride (DOX) nanoparticle...

    Authors: Swati A. Guhagarkar, Sharmila B. Majee, Abdul Samad and Padma V. Devarajan
    Citation: Cancer Nanotechnology 2011 2:12
  20. The conventional chemotherapeutic agents used in the treatment of human malignancies are directed nonspecifically against both malignant and nonmalignant cells, often limiting their efficacy with having seriou...

    Authors: Hirak Kumar Patra, Anjan Kr. Dasgupta, Sounik Sarkar, Indranil Biswas and Arnab Chattopadhyay
    Citation: Cancer Nanotechnology 2011 2:11
  21. To develop a suitable formulation with high entrapment efficiency, etoposide-loaded poly(lactide-co-glycolide) nanoparticles (NPs) were formulated by single emulsion-solvent evaporation method by changing differe...

    Authors: Moutushy Mitra, Fahima Dilnawaz, Ranjita Misra, Anju Harilal, Rama Shenkar Verma, Sanjeeb K. Sahoo and Subramanian Krishnakumar
    Citation: Cancer Nanotechnology 2010 2:10

    The Erratum to this article has been published in Cancer Nanotechnology 2011 2:s12645-011-0013-9

  22. Targeted nanoparticles have the potential to deliver a large drug payload specifically to cancer cells. Targeting requires that a ligand on the nanoparticle surface interact with a specific membrane receptor o...

    Authors: Honglin Jin, Jonathan F. Lovell, Juan Chen, Kenneth Ng, Weiguo Cao, Lili Ding, Zhihong Zhang and Gang Zheng
    Citation: Cancer Nanotechnology 2010 1:9
  23. Nanoparticles are the new entities that can greatly limit the various side effects of systemic chemotherapy, and that coupled with a targeting moiety enables site-specific delivery of drugs. Folate receptors a...

    Authors: Suphiya Parveen and Sanjeeb K. Sahoo
    Citation: Cancer Nanotechnology 2010 1:6
  24. Circulating tumor cells (CTC) are cells that have detached from primary tumors and circulate in the bloodstream where they are carried to other organs, leading to seeding of new tumors and metastases. CTC have...

    Authors: Balaji Panchapakesan, Robert Caprara, Vanessa Velasco, James Loomis, Ben King, Peng Xu, Tom Burkhead, Palaniappan Sethu, L. Jay Stallons, W. Glenn McGregor, Shesh N. Rai, Goetz Kloecker and Eric Wickstrom
    Citation: Cancer Nanotechnology 2010 1:7
  25. Applications of nanoparticles (NPs) as photothermal (PT) and photoacoustic (PA) labels and agents for diagnosis and therapy of cancer and other diseases in laser medicine are fast growing areas of research. Ma...

    Authors: Victor K. Pustovalov, L. G. Astafyeva, E. Galanzha and V. P. Zharov
    Citation: Cancer Nanotechnology 2010 1:5
  26. The present study was designed to explore the ability of polymeric nanoparticles to restore drug sensitivity to P-glycoprotein over-expressing cancer cells. A multidrug-resistant cell line 2780 AD and its sens...

    Authors: V. Bhardwaj, J. A. Plumb, J. Cassidy and M. N. V. Ravi Kumar
    Citation: Cancer Nanotechnology 2010 1:4
  27. In this study, we report the preparation, luminescence, and targeting properties of folic acid-CdTe quantum dot conjugates. Water-soluble CdTe quantum dots were synthesized and conjugated with folic acid using...

    Authors: Preethi Suriamoorthy, Xing Zhang, Guiyang Hao, Alan G. Joly, Surya Singh, Marius Hossu, Xiankai Sun and Wei Chen
    Citation: Cancer Nanotechnology 2010 1:3
  28. The application of nanomaterial in cancer treatment is promising and intriguing. Anti-tumor immunotherapy has the potential to significantly improve the prognosis of cancer treatment, though the efficacy of im...

    Authors: Zhao Sun, Wei Wang, Rui Wang, Jinhong Duan, Yan Hu, Jin Ma, Jiayan Zhou, Sishen Xie, Xin Lu, Zhaohui Zhu, Shuchang Chen, Yuanli Zhao, Haiyan Xu, Chen Wang and Xian-Da Yang
    Citation: Cancer Nanotechnology 2010 1:1
  29. In the present communication, we report the fabrication of a unique core-shell inorganic nanomaterial with potential therapeutic and diagnostic functions. It contains an iron–cobalt (FeCo) core that demonstrat...

    Authors: Chitta Ranjan Patra, Ying Jing, Yun-Hao Xu, Resham Bhattacharya, Debabrata Mukhopadhyay, James F. Glockner, Jian-Ping Wang and Priyabrata Mukherjee
    Citation: Cancer Nanotechnology 2010 1:2

Journal Metrics